The 3 biggest disappointments during earnings season

The G8 Education Ltd (ASX:GEM) result was one of three major disappointments during earnings season…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Yesterday I looked at three key highlights during earnings season. These included bumper profit growth from tech star Altium Limited (ASX: ALU) and an impressive turnaround by retail conglomerate Super Retail Group Ltd (ASX: SUL).

Unfortunately, not all companies had a successful earnings season. Three of the biggest disappointments during the month in my opinion are summarised below:

G8 Education Ltd (ASX: GEM)

Last month G8 Education released its half year results and revealed a 7.6% increase in revenue, but a 21% decline in underlying earnings before interest and tax on the prior corresponding period. The poor result was driven by another drop in the childcare operator's occupancy levels and higher staff costs. G8 Education finished the period with an occupancy level of just 70.1% due to the impact of an oversupply of childcare centres. Unfortunately, I don't see this issue going away any time soon, making G8 Education one to avoid.

Greencross Limited (ASX: GXL)

In FY 2018 this integrated pet care company posted statutory net profit after tax of $20.7 million, down 51% on the prior year. This led to the Greencross board reducing its FY 2018 dividend by 18% to 15.5 cents per share. While it has reported a reasonably solid start to FY 2019, I feel it is still a little soon to invest and expect another underwhelming year from the company. This was recently echoed by Deutsche Bank when it slapped a sell rating and $3.70 price target on the company's shares.

Ramsay Health Care Limited (ASX: RHC)

While I was expecting this private hospital operator to deliver a weak full year result in FY 2018, I was still taken by surprise by how weak it was and how soft its guidance for the year ahead was. Due to tough trading conditions across its whole business, management expects Ramsay to grow core EPS by up to 2% in FY 2019. Although it is a high quality company, I think its shares are overvalued given its current growth profile.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Greencross Limited. The Motley Fool Australia owns shares of Altium and Super Retail Group Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »